The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–240 of 240
Stebbing, J., Dalgleish, A., Gifford-Moore, A., Martin, A., Gleeson, C., Wilson, G., Brunet, L. R., Grange, J., & Mudan, S. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr363 · Cited by 55
Sirokay, J. D., Cron, M., Landsberg, J., Bald, T., Renn, M., Mikus, S., Bondong, S., Wikasari, D., Gaffal, E., Hartmann, G., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0579 · Cited by 55
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade
Huss, D. J., Mehta, D. S., Sharma, A., You, X., Riester, K. A., Sheridan, J. P., Amaravadi, L. S., Elkins, J. S., & Fontenot, J. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402140 · Cited by 55
Vertuani, S., Triulzi, C., Roos, A., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0587-1 · Cited by 55
Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells
Arina, A., & Bronte, V. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.006 · Cited by 54
The Fate of Low Affinity Tumor-Specific CD8+ T Cells in Tumor-Bearing Mice
Lyman, M. A., Nugent, C., Marquardt, K., Biggs, J., Pamer, E. G., & Sherman, L. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2563 · Cited by 54
Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer
Arens, R., van Hall, T., van der Burg, S. H., OSSENDORP, F. A., & Melief, C. J. M. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.008 · Cited by 52
Self-citationWelters, M. J. P., Bijker, M. S., van den Eeden, S. J. F., Franken, K. L. M. C., Melief, C. J. M., Offringa, R., & van der Burg, S. H. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.049 · Cited by 51
Self-citationSato, Y., Fujiwara, T., Mine, T., Shomura, H., Homma, S., Maeda, Y., Tokunaga, N., Ikeda, Y., Ishihara, Y., Yamada, A., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00498.x · Cited by 50
Optimal dose and schedule of an HER‐2/neu (E75) peptide vaccine to prevent breast cancer recurrence
Holmes, J. P., Gates, J. D., Benavides, L. C., Hueman, M. T., Carmichael, M. G., Patil, R., Craig, D., Mittendorf, E. A., Stojadinovic, A., Ponniah, S., et al. (2008) · Cancer · doi:10.1002/cncr.23772 · Cited by 50
Immunotherapy for persistent viral infections and associated disease
van der Burg, S. H., Arens, R., & Melief, C. J. M. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.12.006 · Cited by 50
Self-citationLy, L. V., Sluijter, M., Versluis, M., Luyten, G. P. M., van der Burg, S. H., Melief, C. J. M., Jager, M. J., & van Hall, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2288 · Cited by 50
Self-citationIFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity
Lattanzi, L., Rozera, C., Marescotti, D., D’Agostino, G., Santodonato, L., Cellini, S., Belardelli, F., Gavioli, R., & Ferrantini, M. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.10.003 · Cited by 49
Chemotherapy Induces Macrophage ChemoattractantProtein-1 Production in Ovarian Cancer
Geller, M. A., Bui-Nguyen, T. M., Rogers, L. M., & Ramakrishnan, S. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181e5c442 · Cited by 47
The Quantity of Autocrine IL-2 Governs the Expansion Potential of CD8+ T Cells
Redeker, A., Welten, S. P. M., Baert, M. R. M., Vloemans, S. A., Tiemessen, M. M., Staal, F. J. T., & Arens, R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501083 · Cited by 47
Self-citationvan Esch, E. M. G., Tummers, B., Baartmans, V., Osse, E. M., ter Haar, N. T., Trietsch, M. D., Hellebrekers, B. W. J., Holleboom, C. A. G., Nagel, H., Tan, L. T., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28713 · Cited by 46
New Role of Signal Peptide Peptidase To Liberate C-Terminal Peptides for MHC Class I Presentation
Oliveira, C. C., Querido, B. J., Sluijter, M., de Groot, A. F., van der Zee, R., Rabelink, M. J. W. E., Hoeben, R. C., OSSENDORP, F. A., van der Burg, S. H., & van Hall, T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301496 · Cited by 45
Self-citationDurgeau, A., Hage, F. E., Vergnon, I., Validire, P., de Montpréville, V., Besse, B., Soria, J., van Hall, T., & Mami‐Chouaib, F. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102060 · Cited by 44
Frequent HLA Class I Loss is an Early Event in Cervical Carcinogenesis
Vermeulen, C. F. W., Jordanova, E. S., Zomerdijk-Nooijen, Y. A., ter Haar, N. T., Peters, A. A. W., & Fleuren, G. J. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.10.011 · Cited by 41
N -Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2
Willems, M. M. J. H. P., Zom, G. G., Khan, S., Meeuwenoord, N. J., Melief, C. J. M., van der Stelt, M., Overkleeft, H. S., Codée, J. D. C., van der Marel, G. A., OSSENDORP, F. A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500722p · Cited by 41
Self-citationCD8+ T Cell Responses against TAP-Inhibited Cells Are Readily Detected in the Human Population
Lampen, M. H., Verweij, M. C., Querido, B. J., van der Burg, S. H., Wiertz, E. J. H. J., & van Hall, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001774 · Cited by 38
Daftarian, P. M., Sharan, R., Haq, W., Ali, S., Longmate, J., Termini, J. S., & Diamond, D. J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.093 · Cited by 37
EGFR-mediated tumor immunoescape
Concha‐Benavente, F., Srivastava, R. M., Ferrone, S., & Ferris, R. L. (2013) · OncoImmunology · doi:10.4161/onci.27215 · Cited by 37
van den Hende, M., van Poelgeest, M. I. E., van der Hulst, J. M., de Jong, J., Drijfhout, J. W., Fleuren, G. J., Valentijn, A. R. P. M., Wafelman, A. R., Slappendel, G. M., Melief, C. J. M., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23502 · Cited by 36
Self-citationA novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens
Seidel, U. J. E., Oliveira, C. C., Lampen, M. H., & van Hall, T. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1160-x · Cited by 35
Chambers, B. J., Grufman, P., Fredriksson, V., Andersson, K., Roseboom, M., Laban, S., Camps, M. G. M., Wolpert, E. Z., Wiertz, E. J. H. J., Offringa, R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1092 · Cited by 35
Vecchi, S., Bufali, S., Uno, T., Wu, T. Y.-H., Arcidiacono, L., Filippini, S., Rigat, F., & O’Hagan, D. T. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.01.002 · Cited by 34
Oliveira, C. C., Querido, B. J., Sluijter, M., Derbinski, J., van der Burg, S. H., & van Hall, T. (2011) · European Journal of Immunology · doi:10.1002/eji.201141836 · Cited by 33
Wouters, M. C. A., Dijkgraaf, E. M., Kuijjer, M. L., Jordanova, E. S., Hollema, H., Welters, M. J. P., van der Hoeven, J. J. M., Daemen, T., Kroep, J. R., Nijman, H. W., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.962397 · Cited by 32
Sin, J., Kim, J., Bae, S. H., Lee, I. H., Park, J. S., & Ryoo, H. M. (2009) · Molecular Therapy · doi:10.1038/mt.2009.32 · Cited by 31
Heys, S. D., Stewart, K. N., McKenzie, E. J., Miller, I. D., Wong, S. Y. C., Sellar, G. C., & Rees, A. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2190-6 · Cited by 30
Mechanisms of Peptide Vaccination in Mouse Models
van Hall, T., & van der Burg, S. H. (2012) · Advances in immunology · doi:10.1016/b978-0-12-396548-6.00003-2 · Cited by 30
Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum
Shastri, N., Nagarajan, N. A., Lind, K. C., & Kanaseki, T. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.11.006 · Cited by 29
Singh, S., Meyering, M., Ramwadhdoebé, T. H., Stynenbosch, L. F. M., Redeker, A., Kuppen, P. J. K., Melief, C. J. M., Welters, M. J. P., & van der Burg, S. H. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1251-3 · Cited by 27
Self-citationHuang, X., Huang, G., Song, H., & Chen, L. (2010) · International Journal of Cancer · doi:10.1002/ijc.25702 · Cited by 27
Álvarez, I., Collado, J. A., Colobrán, R., Carrascal, M., Ciudad, M. T., Canals, F., James, E. A., Kwok, W. W., Gärtner, M., Kyewski, B., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.03.004 · Cited by 26
Arina, A., Schreiber, K., Binder, D. C., Karrison, T. G., Liu, R. B., & Schreiber, H. W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202498 · Cited by 19
Oliveira, C. C., Sluijter, M., Querido, B. J., OSSENDORP, F. A., van der Burg, S. H., & van Hall, T. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.006 · Cited by 18
Self-citationTapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy
Kraynyak, K. A., Bodles-Brakhop, A. M., & Bagarazzi, M. L. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_431 · Cited by 12
Recent progress in peptide vaccination in cancer with a focus on non-small-cell lung cancer
Yazdi, M. T., Keene, K. R., Hiemstra, P. S., & van der Burg, S. H. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2014.862499 · Cited by 4
Cited by
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
CD4+ T cell help in cancer immunology and immunotherapy
Borst, J., Ahrends, T., Bąbała, N., Melief, C. J. M., & Kastenmüller, W. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0044-0 · Cited by 1,585
Self-citationSaxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Self-citationEngineered T cells: the promise and challenges of cancer immunotherapy
Fesnak, A. D., June, C. H., & Levine, B. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.97 · Cited by 1,074
Targeting drugs to tumours using cell membrane-coated nanoparticles
Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980
Metadata
- Authors
- van der Burg, S. H., Arens, R., Ossendorp, F., van Hall, T., & Melief, C. J. M.
- Venue
- Nature Reviews Cancer
- Published
- 2016-03-11
- Volume
- 16
- Issue
- 4
- Pages
- 219-233
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2295202170
- Cited by
- 709
- References
- 240
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.